In April, Mylan (NYSE: MYL) offered to acquire Israeli rival Perrigo (NYSE: PRGO) with Perrigo rebuffing that and a second offer from Mylan. That could send Mylan shopping elsewhere or turn it into a target. [Mylan Offer for Perrigo Boosts Pharma ETFs]
Those stocks combine for nearly 5% of PPH’s weight.
Market Vectors Pharmaceutical ETF
ETF Trends editorial team contributed to this post.